Eva Kritikou

763 total citations
13 papers, 626 citations indexed

About

Eva Kritikou is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Eva Kritikou has authored 13 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Eva Kritikou's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Mast cells and histamine (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Eva Kritikou is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Mast cells and histamine (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Eva Kritikou collaborates with scholars based in Netherlands, United Kingdom and United States. Eva Kritikou's co-authors include Ilze Bot, Johan Kuiper, Thomas van der Heijden, Janine van Duijn, Bram Slütter, Amanda C. Foks, Peter J. van Santbrink, Arko Gorter, Gert Jan Fleuren and Erik Lubberts and has published in prestigious journals such as Circulation, The Journal of Immunology and Scientific Reports.

In The Last Decade

Eva Kritikou

13 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Kritikou Netherlands 10 361 347 114 107 91 13 626
Mitsumi Arito Japan 14 120 0.3× 284 0.8× 83 0.7× 77 0.7× 63 0.7× 44 579
Anouk Wezel Netherlands 18 427 1.2× 191 0.6× 92 0.8× 94 0.9× 27 0.3× 30 648
Teresa Gerhardt Germany 6 345 1.0× 160 0.5× 87 0.8× 92 0.9× 59 0.6× 11 563
Junko Tsubaki Japan 11 131 0.4× 371 1.1× 81 0.7× 63 0.6× 140 1.5× 17 894
Riina Oksjoki Finland 12 435 1.2× 146 0.4× 162 1.4× 115 1.1× 24 0.3× 17 759
Nandita S. Raikwar United States 17 93 0.3× 333 1.0× 64 0.6× 57 0.5× 60 0.7× 27 620
Flora Saint-Charles France 11 354 1.0× 147 0.4× 164 1.4× 135 1.3× 42 0.5× 14 604
Susann Lucke Germany 7 124 0.3× 450 1.3× 98 0.9× 56 0.5× 20 0.2× 9 638
Marcus D. Skaflen United States 13 260 0.7× 284 0.8× 224 2.0× 122 1.1× 127 1.4× 13 665
Yune‐Jung Park South Korea 12 119 0.3× 164 0.5× 37 0.3× 73 0.7× 43 0.5× 23 482

Countries citing papers authored by Eva Kritikou

Since Specialization
Citations

This map shows the geographic impact of Eva Kritikou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kritikou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kritikou more than expected).

Fields of papers citing papers by Eva Kritikou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kritikou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kritikou. The network helps show where Eva Kritikou may publish in the future.

Co-authorship network of co-authors of Eva Kritikou

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kritikou. A scholar is included among the top collaborators of Eva Kritikou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kritikou. Eva Kritikou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kritikou, Eva, Jan Nilsson, Harry Björkbacka, et al.. (2022). LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice. JACC CardioOncology. 4(5). 635–645. 19 indexed citations
2.
Vromman, Amélie, Shamsudheen Karuthedath Vellarikkal, Mariana Janini Gomes, et al.. (2020). Abstract 15355: Interleukin-1beta Inhibition Attenuates Accelerated Atherosclerosis in Mice With Tet2 Loss of Function in a Sex-dependent Fashion. Circulation. 142(Suppl_3). 1 indexed citations
3.
Kritikou, Eva, Thomas van der Heijden, Maarten Swart, et al.. (2019). Hypercholesterolemia Induces a Mast Cell–CD4+ T Cell Interaction in Atherosclerosis. The Journal of Immunology. 202(5). 1531–1539. 17 indexed citations
4.
Kritikou, Eva, Marie A.C. Depuydt, Margreet R. de Vries, et al.. (2019). Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis. Cells. 8(4). 334–334. 30 indexed citations
5.
Kritikou, Eva, Janine van Duijn, Thomas van der Heijden, et al.. (2018). Disruption of a CD1d-mediated interaction between mast cells and NKT cells aggravates atherosclerosis. Atherosclerosis. 280. 132–139. 14 indexed citations
6.
Duijn, Janine van, Eva Kritikou, Naomi Benne, et al.. (2018). CD8+ T-cells contribute to lesion stabilization in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses. Cardiovascular Research. 115(4). 729–738. 56 indexed citations
7.
Kritikou, Eva, Thomas van der Heijden, Maarten Swart, et al.. (2017). Hypercholesterolemia induces a mast cell-CD4+ T-cell interaction in atherosclerosis. Atherosclerosis. 263. e124–e124. 1 indexed citations
8.
Heijden, Thomas van der, Eva Kritikou, Janine van Duijn, et al.. (2017). NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 37(8). 1457–1461. 291 indexed citations
9.
Kritikou, Eva, Gijs H.M. van Puijvelde, Thomas van der Heijden, et al.. (2016). Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice. Scientific Reports. 6(1). 37585–37585. 29 indexed citations
10.
Punt, Simone, Gert Jan Fleuren, Eva Kritikou, et al.. (2015). Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer. OncoImmunology. 4(1). e984539–e984539. 96 indexed citations
11.
Kritikou, Eva, Johan Kuiper, Petri T. Kovanen, & Ilze Bot. (2015). The impact of mast cells on cardiovascular diseases. European Journal of Pharmacology. 778. 103–115. 28 indexed citations
12.
Punt, Simone, Iris A. Schulkens, Victor L. Thijssen, et al.. (2014). A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations
13.
Σπέλλα, Μάγδα, Christina Kyrousi, Eva Kritikou, et al.. (2011). Geminin Regulates Cortical Progenitor Proliferation and Differentiation. Stem Cells. 29(8). 1269–1282. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsumi Arito Breakdown of academic impact, for papers by Anouk Wezel Breakdown of academic impact, for papers by Teresa Gerhardt Breakdown of academic impact, for papers by Junko Tsubaki Breakdown of academic impact, for papers by Riina Oksjoki Breakdown of academic impact, for papers by Nandita S. Raikwar Breakdown of academic impact, for papers by Flora Saint-Charles Breakdown of academic impact, for papers by Susann Lucke Breakdown of academic impact, for papers by Marcus D. Skaflen Breakdown of academic impact, for papers by Yune‐Jung Park
Rankless by CCL
2026